PUBLISHER: Market Xcel - Markets and Data | PRODUCT CODE: 1564654
PUBLISHER: Market Xcel - Markets and Data | PRODUCT CODE: 1564654
The global CT scanners market is projected to witness a CAGR of 6.11% during the forecast period 2024-2031, growing from USD 6,344.42 million in 2023 to USD 10,196.29 million in 2031. The surge in chronic diseases like cancer, cardiovascular, and neurological disorders, advancements in CT scanner technology, increasing awareness of early disease detection, and improvements in treatment are expected to drive growth in the CT scanners market in the forecast period.
CT scanners are an imperative diagnostic tool, providing cross-sectional images of internal structures and abnormalities. These images are detailed 3D representations crucial for early disease diagnosis. Thus, increasing demands for such diagnostic tools in healthcare settings and growing ambulatory surgical departments are various factors that can positively impact the CT scanners market. Furthermore, new product launches and the integration of advanced technologies in CT scanners are expected to bring new opportunities to drive the market. For instance, in July 2024, Trivitron Healthcare Pvt. Ltd. launched the Terrene CT scanner in India. It has received approvals from organizations like the Atomic Energy Regulatory Board, the Bureau of Indian Standards, and the Central Drugs Standard Control Organization. It has made a significant impact on India's healthcare industry. Moreover, Canon Medical Systems Corporation, in February 2024, completed the second global installation of its Canon photon-counting CT (PCCT) system at Radboud University Medical Center in Nijmegen. Clinical research with this advanced PCCT technology commenced in late January. The PCCT represents the next evolution in X-ray CT technology.
Increasing Prevalence of Targeted Diseases Impacting CT Scanners Market
An increase in the burden of certain diseases, such as cancer, drives a growing demand for advanced diagnostic devices and substantially impacts the CT scanners market. With the incidences of tumors and pulmonary embolisms on the rise, healthcare professionals are seeking more accurate and efficient imaging solutions to aid in the early detection of such conditions and find appropriate treatments. This growing demand drives market growth, innovation, and advancements in CT scanner technology. Enhanced diagnostic capabilities and expanded clinical application significantly influence the expansion of the market. The demand for comprehensive imaging solutions to diagnose and treat these conditions further fuels continuous investments and improvements within the CT scanner industry. According to the World Health Organization (WHO), the global cancer burden is rising, and thus there is a need to provide diagnostic services. The International Agency for Research on Cancer (IARC) agency estimated that in 2022, there are about 20 million new cancer cases and 9.7 million cancer-related deaths worldwide. This justifies the need for better early-detection facilities. CT scanners offer several merits, including high-resolution and fast imaging capabilities, contrast-enhanced imaging, and detailed cross-sectional views, thus making these modalities play an important role in tumor diagnosis. As the incidence of these diseases increases, the demand for more accurate and efficient CT scanners will increase to support the market.
Rising Technological Advancements in CT Scanners
The new technologies stimulate the growth of the global CT scanner market. Artificial intelligence improves not only diagnosis accuracy but also streamlines workflow. It is accompanied by a better-quality image for further acceleration and high precision at the time of diagnosis. For example, in February 2024, Koninklijke Philips N.V. launched CT 5300 an advanced system that involves AI capabilities with accuracy in diagnosis at a low cost. This advanced system delivers improved imaging resolution and accuracy, which is quite helpful for the scanning of complex cardiac cases involving detailed evaluation of the patient. This system aims at enhancing productivity and diagnostic accuracy in understaffed, in-demand radiology departments. That kind of integration of AI into CT scanners propels the CT scanners market. More recently, in November 2023, at the annual Radiological Society of North America (RSNA) meeting, NeuroLogica Corporation, a subsidiary of Samsung Electronics, unveiled the new OmniTom Elite Photon Counting mobile CT scanner. This novel system features a single-source photon counting technology, delivering improved image quality, streamlined workflows, and advanced AI integration. As the technology develops, it boosts investments, expanding the CT scanner market.
Dominance of High-slice Technology in the CT Scanners Market
The high-slice segment held the market for CT scanners and took the highest share from the market due to highly advanced imaging capabilities and improved performance. It is better than the low-slice and mid-slice as it can capture more slices in a single rotation, reducing the scan times. High-slice systems, which can capture more detailed cross-sectional images, have become the most favored system because they can deliver comprehensive diagnostic information quickly and accurately. Their enhanced resolution and efficiency make them indispensable in various clinical settings, which drive their dominance in the market. High-slice CT scanners comparatively lower the patient radiation dose compared to others, which may lead to its dominance. For instance, in June 2024, Fujifilm Holdings Corporation got the US FDA 510(k) clearance for its FCT iStream, a 128-slice computed tomography system. It is engineered to cut radiation exposure to patients. Thus, it is likely to increase patient comfort, thereby generating more demand.
North America Dominates CT Scanners Market Share
North America held the largest market share in the global CT scanners market. The reasons for this are the high prevalence of diseases, such as cancer and cardiovascular and neurological disorders, which have made the requirement for improved and upgraded imaging solutions. Strategic collaborations of key market players in the region, rising investments and expanding budgets of end-user facilities also contribute to strengthen the market in North America. For example, in April 2024, Lake Cumberland Regional Hospital installed the 256-slice CT scanner with a 160 mm detector, marking a significant advancement in their healthcare technology for the patients. This installation represents a substantial investment, with more than USD 2.2 Million. This commitment underscores the hospital's ongoing dedication to improving healthcare services and meeting the needs of its patients. Moreover, in March 2024, GigCapital Inc., an investment firm, completed its acquisition of QT Imaging Holdings, Inc., a California-based company known for its development of medical technology, including QT Imaging Holdings, Inc. breast acoustic CT scanner.
Future Market Scenario (2024-2031F)
Breast CT scanners are advancing toward higher-resolution imaging and improved detection of tumor biology, offering a more comfortable alternative to traditional breast cancer imaging techniques. Research is ongoing, with efforts to commercialize breast CT, for instance, University of California, Davis Health (UC Davis Health) is making significant efforts towards commercialization of Brest CT. Researchers at UC Davis Health have focused on the scanner's ability to identify small calcium deposits, which are important for early breast cancer detection. Continuous advancements are aimed at integrating breast CT into clinical practice, ultimately improving early detection and treatment outcomes for breast cancer.
Advancements in scanner technology are vital for the growth of the CT scanners market. The potential integration of AI into cone-beam computed tomography (CBCT) scans could improve the efficiency and accuracy of scan analysis. There are promising futures for dental CBCT technology, including compact design, among other innovations. The developments in 3D printing and digital dentistry are thought to be very closely related to CBCT technology and will thus improve the efficacy and accuracy of dental practice.
Key Players Landscape and Outlook
The global market for CT scanners is highly consolidated with major players like Siemens Healthineers AG, GE HealthCare Technologies Inc., Canon Medical Systems Corporation, and Koninklijke Philips N.V, together holding all major market shares. New product launches, mergers, and acquisitions, along with rising collaborations for the expansion of existing products, are the most followed market strategies observed in recent times.
In January 2024, GE HealthCare Technologies Inc. (GE HealthCare), acquired MIM Software Inc. from a provider of medical imaging analysis and artificial intelligence solutions for radiation oncology. This acquisition mainly propels the advancement of technology in GE HealthCare. By integrating MIM Software's advanced imaging analytics and AI-based tools with the innovative medical technology at GE HealthCare, the company is enhancing its capabilities while further advancing precision care for the future.
In November 2023, Siemens Healthineers AG In November 2023, invested USD 86 million in the expansion of its photon-counting CT scanner manufacturing in Germany. It is now targeting to introduce more than ten functionalities to improve the photon-counting performance, especially in the cardiac arena.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.